Research progress and CMC review considerations of MF59 vaccine adjuvant

XU Li, ZHAO Xin, LIU Min, LI Min

PDF(2353 KB)
PDF(2353 KB)
Chinese Journal of New Drugs ›› 2025, Vol. 34 ›› Issue (6) : 656-664. DOI: 10.20251/j.cnki.1003-3734.2025.06.016

Research progress and CMC review considerations of MF59 vaccine adjuvant

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 34(6): 656-664 https://doi.org/10.20251/j.cnki.1003-3734.2025.06.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2353 KB)

Accesses

Citation

Detail
Sections
Recommended
Total:
Copyright © Chinese Journal of New Drugs, All Rights Reserved.
Tel: 010-52722697 | 010-52723707
　 Powered by Beijing Magtech Co., Ltd.

/

〈 〉